| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.260 | 5.938 | 42.949 | 54.379 | 93.903 |
| Total Income - EUR | - | - | - | - | - | 2.260 | 5.938 | 42.949 | 54.379 | 93.903 |
| Total Expenses - EUR | - | - | - | - | - | 5.117 | 12.750 | 24.487 | 46.670 | 71.983 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -2.857 | -6.812 | 18.462 | 7.710 | 21.919 |
| Net Profit/Loss - EUR | - | - | - | - | - | -2.857 | -6.909 | 17.673 | 7.213 | 19.524 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Doctor Paul Man S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 3.705 | 29.977 |
| Current Assets | - | - | - | - | - | 410 | 1.118 | 8.453 | 13.504 | 15.001 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 2.479 | 13.099 |
| Receivables | - | - | - | - | - | 291 | 285 | 365 | 285 | 385 |
| Cash | - | - | - | - | - | 118 | 833 | 8.088 | 10.741 | 1.517 |
| Shareholders Funds | - | - | - | - | - | -2.816 | -9.663 | 7.980 | 15.169 | 34.608 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 3.226 | 10.781 | 473 | 2.041 | 10.369 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Doctor Paul Man S.r.l.